The Current Ratio as of September 2024 (TTM) for Edgewise Therapeutics, Inc. (EWTX) is 30.24

According to Edgewise Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 30.24. This represents a change of 15.14% compared to the average of 26.26 of the last 4 quarters.

Edgewise Therapeutics, Inc. (EWTX) Historical Current Ratio (quarterly & annually)

How has EWTX Current Ratio performed in the past?

The mean historical Current Ratio of Edgewise Therapeutics, Inc. over the last ten years is 23.70. The current 30.24 Current Ratio has changed 12.66% with respect to the historical average. Over the past ten years (40 quarters), EWTX's Current Ratio was at its highest in in the March 2021 quarter at 64.02. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Edgewise Therapeutics, Inc. (EWTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Edgewise Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Edgewise Therapeutics, Inc. (EWTX) Average Current Ratio

How has EWTX Current Ratio performed in the past?

The current Current Ratio of Edgewise Therapeutics, Inc. (EWTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Edgewise Therapeutics, Inc. (EWTX) Current Ratio vs. Peers

How is EWTX’s Current Ratio compared to its peers?

Edgewise Therapeutics, Inc.’s Current Ratio is greater than Century Therapeutics, Inc. (10.62), greater than C4 Therapeutics, Inc. (5.09), greater than Mineralys Therapeutics, Inc. (11.20), greater than Cullinan Oncology, Inc. (28.87), greater than Talaris Therapeutics, Inc. (18.64), greater than Adicet Bio, Inc. (12.75), greater than Vor Biopharma Inc. (6.54), greater than Ikena Oncology, Inc. (18.22), less than Design Therapeutics, Inc. (41.42), greater than Xilio Therapeutics, Inc. (2.02), less than Eliem Therapeutics, Inc. (60.41), greater than Werewolf Therapeutics, Inc. (12.13), greater than Decibel Therapeutics, Inc. (3.03), greater than Celcuity Inc. (14.95), greater than TCR2 Therapeutics Inc. (2.96), greater than Revolution Medicines, Inc. (15.42), greater than Black Diamond Therapeutics, Inc. (6.87), greater than Atreca, Inc. (1.58), greater than Passage Bio, Inc. (7.67),

Build a custom stock screener for Edgewise Therapeutics, Inc. (EWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edgewise Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Edgewise Therapeutics, Inc. (EWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Edgewise Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.